Last SFr.80.30 CHF
Change Today +0.70 / 0.88%
Volume 1.2M
NOVN On Other Exchanges
Symbol
Exchange
SIX Swiss Ex
Xetra
New York
OTC US
Mexico
Frankfurt
SIX Swiss Ex
As of 7:45 AM 07/14/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

George Gunn BVM&S, DVSM, MRCVS.

Division Head of Animal Health and Member of Executive Committee, Novartis AG
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 4 different industries.

63SFr.3,952,279
As of Fiscal Year 2013

Background*

Mr. George Gunn, BVM&S, DVSM, MRCVS serves as the Chief Executive Officer at Novartis Animal Health Inc. Mr. Gunn serves as been the Head of Animal Health at Novartis AG since January 2004 and served as its Head of Corporate Responsibility since March 2011. He served as Chief Executive Officer of Consumer Health Division, an affiliate of Novartis Institutes for BioMedical Research, Inc. from December 2008 to 2011. He served as the Head of the Novartis Consumer Health ...

Read Full Background

Corporate Headquarters*

Lichtstrasse 35
Basel, Basel-Stadt 4056

Switzerland

Phone: 41 61 324 11 11
Fax: --

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

MS
University of Edinburgh in Scotland
Unknown/Other Education 1978
Royal (Dick) School of Veterinary Studies
Honorary Doctorate
Royal (Dick) School of Veterinary Studies
Bachelor's Degree 1973
Royal (Dick) School of Veterinary Studies

Other Affiliations*

Annual Compensation*

SalarySFr.865,000
BonusSFr.545,000
Total Annual CompensationSFr.1,410,000

Stock Options*

Restricted Stock AwardsSFr.2,377,921
All Other CompensationSFr.164,358
Total Number of Options94,371

Total Compensation*

Total Annual Cash CompensationSFr.1,574,358
Total Short Term CompensationSFr.1,410,000
Other Long Term CompensationSFr.2,542,279
Total Calculated CompensationSFr.3,952,279
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
NOVN:VX SFr.80.30 CHF +0.70

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
John C. Martin Ph.D.Chairman and Chief Executive Officer
Gilead Sciences Inc.
$1.6M
Alan George Lafley Chairman of the Board, Chief Executive Officer, President and Member of Proxy Committee
The Procter & Gamble Company
$1.8M
Marijn E. Dekkers Ph.D.Chairman of Management Board and Chief Executive Officer
Bayer AG
€2.9M
Inge G. Thulin Chairman, Chief Executive Officer and President
3M Company
$1.3M
Lars Rebien Sørensen Chief Executive Officer
Novo Nordisk A/S
kr15.2M
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact NOVARTIS AG-REG, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.